US Broker Ratings

Bausch + Lomb Corporation (BLCO)

⚠️ No article content returned.

..

Vaxcyte, Inc. (PCVX) Stock Analysis: Eyeing a 92.4% Upside with Innovative Vaccine Pipeline

For investors with an appetite for groundbreaking biotechnology ventures, Vaxcyte, Inc. (NASDAQ: PCVX) presents an enticing opportunity. Specializing in the development of novel vaccines for bacterial..

Alkermes plc (ALKS) Stock Analysis: A Promising 35.46% Upside Amid Strong Revenue Growth

Alkermes plc (NASDAQ: ALKS) presents an intriguing opportunity for investors seeking exposure in the healthcare sector, particularly within the specialty and generic drug manufacturing industry. Based..

Charles River Laboratories (CRL) Stock Analysis: Navigating Potential Upside in the Healthcare Sector

Charles River Laboratories International, Inc. (NYSE: CRL) presents a compelling narrative for investors seeking exposure to the healthcare sector, specifically within the diagnostics and research industry...

Ionis Pharmaceuticals (IONS) Investor Outlook: Exploring a 92% Potential Upside Amidst Biotech Challenges

Investors with a keen interest in the biotechnology sector may find Ionis Pharmaceuticals, Inc. (NASDAQ: IONS) a compelling consideration, given its current stock dynamics and substantial..

iRhythm Holdings, Inc. (IRTC) Stock Analysis: Target Price Signals a Promising 59.59% Upside

iRhythm Holdings, Inc. (NASDAQ: IRTC), a prominent player in the medical devices sector, is making waves in the digital healthcare arena with its innovative cardiac monitoring..

Chemed Corp (CHE) Stock Analysis: Exploring a 12.63% Upside Potential for Investors

Chemed Corp (NYSE: CHE), a prominent player in the healthcare sector, particularly within the medical care facilities industry, offers an intriguing investment case for those interested..

Option Care Health, Inc. (OPCH) Stock Analysis: Exploring a 26.25% Upside Potential

Option Care Health, Inc. (NASDAQ: OPCH) stands as a significant player in the healthcare sector, particularly within the medical care facilities industry. Headquartered in Bannockburn, Illinois,..

Haleon plc (HLN) Stock Analysis: Exploring a 35% Potential Upside in the Healthcare Sector

Haleon plc (HLN) has emerged as a noteworthy player in the healthcare sector, particularly within the drug manufacturers’ specialty and generic industry. With a market capitalization..

Oscar Health, Inc. (OSCR) Stock Analysis: Exploring the 14.41% Potential Upside

Oscar Health, Inc. (NYSE: OSCR), a prominent player in the healthcare plans sector, is garnering significant attention from investors, primarily due to its impressive revenue growth..

BrightSpring Health Services, Inc. (BTSG): Analyst Consensus Indicates 31% Upside Potential

Investors looking for promising opportunities in the healthcare sector may want to consider BrightSpring Health Services, Inc. (BTSG), a leading player in the health information services..

Revolution Medicines, Inc. (RVMD) Stock Analysis: A Promising Biotech with a 24.60% Upside

Revolution Medicines, Inc. (NASDAQ: RVMD) stands as a beacon of innovation in the biotechnology industry, focusing on the development of novel targeted therapies for RAS-addicted cancers...

TransMedics Group, Inc. (TMDX) Stock Analysis: A Promising 21.94% Upside for Investors in the Medical Device Sector

TransMedics Group, Inc. (NASDAQ: TMDX) has emerged as a key player in the medical device industry, focusing on innovative solutions for organ transplant therapy. With a..

Roivant Sciences Ltd. (ROIV)

⚠️ No article content returned.

..

ICON plc (ICLR)

⚠️ No article content returned.

..

Lantheus Holdings, Inc. (LNTH) Stock Analysis: A Healthcare Player with a Robust 7.78% Growth Potential

Lantheus Holdings, Inc. (NASDAQ: LNTH) emerges as a noteworthy contender in the healthcare sector, specifically within the specialty and generic drug manufacturing industry. The company, with..

Halozyme Therapeutics, Inc. (HALO): Investor Outlook on a Biotech Powerhouse with Robust Revenue Growth

Halozyme Therapeutics, Inc. (NASDAQ: HALO) stands out in the biotechnology sector with a market capitalization of $12.47 billion. This San Diego-based biopharmaceutical company has carved a..

Stevanato Group S.p.A. (STVN): Investor Outlook with a 22.15% Upside Potential

Stevanato Group S.p.A. (NYSE: STVN) is catching the attention of investors with its promising position in the healthcare sector, specifically in the medical instruments and supplies..

Glaukos Corporation (GKOS) Stock Analysis: A Healthcare Innovator with a 21% Potential Upside

Glaukos Corporation (NYSE: GKOS), a pioneering entity in the realm of ophthalmic pharmaceuticals and medical technology, is capturing the attention of investors with its promising growth..

Cytokinetics, Incorporated (CYTK) Stock Analysis: Potential 67.53% Upside Amid Biotech Innovations

Cytokinetics, Incorporated (NASDAQ: CYTK), a biopharmaceutical powerhouse based in South San Francisco, California, is making waves in the biotechnology sector with its innovative muscle activators and..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds